Yves Ribeill

SCY-635, a Novel Nonimmunosuppressive Analog of Cyclosporine That Exhibits Potent Inhibition of Hepatitis C Virus RNA Replication<i>In Vitro</i>

Sam Hopkins, Bernard Scorneaux, Zhuhui Huang et al. · Antimicrobial Agents and Chemotherapy · 2009 · 136 citations · Full text

Betulinic Acid Derivatives:  A New Class of Human Immunodeficiency Virus Type 1 Specific Inhibitors with a New Mode of Action

Michel Evers, Christèle Poujade, Françoise Soler et al. · Journal of Medicinal Chemistry · 1996 · 124 citations

The cyclophilin inhibitor SCY-635 suppresses viral replication and induces endogenous interferons in patients with chronic HCV genotype 1 infection

Sam Hopkins, Betty DiMassimo, Pamela Rusnak et al. · Journal of Hepatology · 2012 · 90 citations

Viral Persistence, Viral Hepatitis, Pathogenesis +8

89 SAFETY, PLASMA PHARMACOKINETICS, AND ANTI-VIRAL ACTIVITY OF SCY-635 IN ADULT PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION

Scarlett E. Hopkins, Douglas M. Heuman, Edith Gavis et al. · Journal of Hepatology · 2009 · 25 citations · Full text

Hepatology, Hepatitis C, Viral Hepatitis +7

Indeno[1,2-<i>b</i>]pyrazin-2,3-diones: A New Class of Antagonists at the Glycine Site of the NMDA Receptor with Potent in Vivo Activity

Patrick Jimonet, Yves Ribeill, Georg Andrees Böhme et al. · Journal of Medicinal Chemistry · 2000 · 23 citations